Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06476145 · ClinicalTrials.gov registry record
Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation
A clinical trial of Adenoma Colon Polyp, sponsored by AdventHealth.
- Recruiting
- Registry status
- 342
- Enrollment target
- 1
- Study location
NCT06476145: Recruiting study of Adenoma Colon Polyp, sponsored by AdventHealth.
NCT06476145 is a study of Adenoma Colon Polyp that is actively recruiting participants, run by AdventHealth. The registered enrollment target is 342 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06476145, a study of Adenoma Colon Polyp, is actively recruiting participants, sponsored by AdventHealth.
- RECRUITING
- Registry status
- 342 participants
- Enrollment target
- 1
- Study location
Study Summary
Non-inferiority trial comparing the recurrence rate of adenomas in non-pedunculated colonic lesions following endoscopic mucosal resection with margin marking (EMR-MM) and endoscopic mucosal resection with thermal margin ablation (EMR-STSC)
Primary Outcome
During Screening Colonoscopy (SC) 1, between 3 -12 post initial procedure. The post-EMR site will be assessed and biopsied for histology to assess for recurrence of adenoma.
Conditions Studied
Study Locations (1)
Florida
- AdventHealth - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 342 participants |
| Start Date | 2023-12-08 |
| Est. Completion | 2027-01-08 |
What NCT06476145 shows while recruiting
NCT06476145 is an observational study that tracks outcomes without assigning an intervention. The registered 342 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Adenoma Colon Polyp appearing as the primary indexed condition, and to 0 interventions.
NCT06476145 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06476145 about?
NCT06476145 is a clinical study titled "Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation". Non-inferiority trial comparing the recurrence rate of adenomas in non-pedunculated colonic lesions following endoscopic mucosal resection with margin marking (EMR-MM) and endoscopic mucosal resection with thermal margin ablation (EMR-STSC)
What is the current status of trial NCT06476145?
This trial is currently recruiting. The enrollment target is 342 participants. The study started on 2023-12-08. Estimated completion is 2027-01-08.
What conditions does trial NCT06476145 study?
This clinical trial studies the following conditions: Adenoma Colon Polyp.
Who is sponsoring clinical trial NCT06476145?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06476145 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283850 · 342 participants · Phase 2
Surviving PEA in Roanoke (SPEAR) Study
- NCT05714085 · 342 participants · Phase 2
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- NCT06188702 · 342 participants · Phase 1
S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP
- NCT06544941 · 342 participants · NA
Improving Maternal Sleep and Mental Health
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI